DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has once again been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA received the distinction in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks in quality of management, value as a long-term investment, effectiveness in conducting business globally and wise use of corporate assets.
“We’re thrilled to be included on FORTUNE’s list of the World’s Most Admired Companies. This recognition is a testament to the dedication of our 55,000+ employees who work every day to ignite advances in data science and human science to transform healthcare decision making,” said IQVIA Chairman and CEO Ari Bousbib. “We are excited to continue to help clients, partners and patients tap into advances in analytics and technologies to find new ways to make healthcare work better for everyone.”
FORTUNE’s World’s Most Admired Companies list is the definitive report card on corporate reputations. Since 1997, FORTUNE has identified, selected and ranked the World’s Most Admired Companies, uncovering the business practices that make these companies highly regarded among their peers.
Most Admired Company Survey Methodology
In compiling the Most Admired list, FORTUNE survey partner Korn Ferry Hay Group surveyed 680 companies from 28 countries asking executives, directors and analysts to rate companies within their own industry on nine reputation drivers considered to be crucial to a company’s global success. These drivers include financial soundness, long-term investment value, people management, social responsibility, use of assets, quality of management, quality of products/services, innovation and global competitiveness. A company’s score must rank in the top half of its industry survey to be listed.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.IQVIA.com.
|From FORTUNE Magazine, February 1, 2018 ©2018 Time Inc. FORTUNE and The World’s Most Admired Companies are registered trademarks of Time Inc. and are used under license.
FORTUNE and Time Inc. are not affiliated with, and do not endorse products or services of, IQVIA.
Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?
We're available during standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in our toll-free list.
Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.